eagle-i Harvard UniversityHarvard University
See it in Search
This page is a preview of the following resource. Continue onto eagle-i search using the button on the right to see the full record.

RIP-rtTA/N

eagle-i ID

http://harvard.eagle-i.net/i/0000012a-25bf-7988-f5ed-943080000012

Resource Type

  1. Mus musculus

Properties

  1. Resource Description
    Development: The transgene encodes the reverse tetracycline regulatable transactivator (rtTA)(Gossen M, Bujard H,1992; Gossen M, BujardH,1995) under the rat insulin promoter (Ins2 or RIP), and is expressed in the pancreatic beta cells. The RIP-rtTA transgenic construct was injected into (C57BL/6J x SJL)F1 oocytes and backcrossed onto the NOD background for 30 generations. Mice hemizygous for this transgenic insert are viable, fertile, normal in size, display normal NOD diabetes onset, and do not display any other gross physical or behavioral abnormalities. This strain provides a Tet-On tool to control the inducible expression of genes in the pancreatic beta cells during various stages of diabetes development. When NOD.RIP-rtTA mice are mated to a second transgenic strain carrying the target gene regulated by the tetO responsive elements, expression of the target gene is turned on by the tetracycline analog, doxycycline (dox). Dox can be administered orally in the food or water.
  2. Related Disease
    type 1 diabetes mellitus
  3. Related Publication or Documentation
    Tight control of gene expression in mammalian cells by tetracycline-responsive promoters.
  4. Related Publication or Documentation
    Transcriptional activation by tetracyclines in mammalian cells.
  5. Parental Strain Name
    C57BL/6J x SJL
  6. Genetic Alteration(s)
    Tetracycline controlled transactivator insertion
  7. Genetic Alteration(s)
    Rat Insulin promoter
  8. Clinical or Environmental Source
    Controlled facility at Jackson labs
  9. Location
    Genetically Modified NOD Mouse Core Facility (HMS)
 
RDFRDF
 
Provenance Metadata About This Resource Record

Copyright © 2016 by the President and Fellows of Harvard College
The eagle-i Consortium is supported by NIH Grant #5U24RR029825-02 / Copyright 2016